PATENT CLAIM ANALYSIS

Application Number: 15870376
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "015200"]

Abstract:
The present invention relates to variants of a parent albumin having altered plasma half-life compared with the parent albumin. The present invention also relates to fusion polypeptides and conjugates comprising said variant albumin.

Claim (Index 14):
The composition of  claim 12 , further comprising one or more excipients.

Metadata:
- Claim Count in Document: 33.0
- Percentile: 86.0
- Lexical Diversity: 1.34615
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13504326', '13640235', '13463944', '14685112', '14385631']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.798724801355089
- 35 USC 102 Novelty (BERT): 0.6028186216511516
- Combined Prediction Score: 0.7791341833846954
- Mean Citation Score: 589.003614
- Max Citation Score: 698.8859
- Similarity Product: 440.1242796498954

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test